Beckman Coulter, Inc. DxI 9000 Access Immunoassay Analyzer running software version 1.16 or prior, Recall
Hazard assessment based on recall description.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
DxI 9000 Access Immunoassay Analyzer running software version 1.16 or prior,
Brand
Beckman Coulter, Inc.
Lot Codes / Batch Numbers
UDI/DI 15099590732103, Serial Numbers: 300116, 300117, 300118, 300123, 300127, 300126, 300128, 300129, 300130, 300131, 300133, 300134, 300135, 300136, 300138, 300139, 300137, 300140, 300142, 300141, 300144, 300143, 300145, 300148 300146, 300147, 300149, 300150, 300151, 300152, 300155, 300153, 300154, 300156, 300158, 300160, 300163, 300161, 300162, 300164, 300167, 300170, 300169, 300171, 300168, 300166, 300172, 300176, 300173, 300178, 300181, 300179, 300183, 300182, 300188, 300189, 300190, 300191, 300192, 300195, 300196, 300193, 300194, 300197, 300199, 300198, 300201, 300200, 300202, 300203, 300205, 300204 300207, 300206, 300208, 300209, 300212, 300210, 300211, 300213, 300214, 300215, 300217, 300216, 300220, 300218, 300219, 300221, 300223, 300224, 300222, 300227, 300228, 300229, 300231, 300230, 300235, 300236, 300234, 300237, 300232, 300239, 300233, 300238, 300240, 300243, 300241, 300242, 300247, 300246, 300249, 300253, 300244, 300250, 300252, 300248, 300251, 300256, 300257, 300254, 300258, 300255, 300259, 300260, 300261, 300264, 300263, 300262, running software version 1.16 or prior
Products Sold
UDI/DI 15099590732103, Serial Numbers: 300116, 300117, 300118, 300123, 300127, 300126, 300128, 300129, 300130, 300131, 300133, 300134, 300135, 300136, 300138, 300139, 300137, 300140, 300142, 300141, 300144, 300143, 300145, 300148 300146, 300147, 300149, 300150, 300151, 300152, 300155, 300153, 300154, 300156, 300158, 300160, 300163, 300161, 300162, 300164, 300167, 300170, 300169, 300171, 300168, 300166, 300172, 300176, 300173, 300178, 300181, 300179, 300183, 300182, 300188, 300189, 300190, 300191, 300192, 300195, 300196, 300193, 300194, 300197, 300199, 300198, 300201, 300200, 300202, 300203, 300205, 300204 300207, 300206, 300208, 300209, 300212, 300210, 300211, 300213, 300214, 300215, 300217, 300216, 300220, 300218, 300219, 300221, 300223, 300224, 300222, 300227, 300228, 300229, 300231, 300230, 300235, 300236, 300234, 300237, 300232, 300239, 300233, 300238, 300240, 300243, 300241, 300242, 300247, 300246, 300249, 300253, 300244, 300250, 300252, 300248, 300251, 300256, 300257, 300254, 300258, 300255, 300259, 300260, 300261, 300264, 300263, 300262; running software version 1.16 or prior
Beckman Coulter, Inc. is recalling DxI 9000 Access Immunoassay Analyzer running software version 1.16 or prior, due to There are potential performance issues found in the DxI 9000 Access Immunoassay Analyzer, including: 1) Access Ultrasensitive Insulin users who config. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
There are potential performance issues found in the DxI 9000 Access Immunoassay Analyzer, including: 1) Access Ultrasensitive Insulin users who configure SI units (pmol/L) applies an incorrect conversion factor; 2) System provides numerical results that are below the lowest reportable result if laboratory chooses to report assay results in units of measurement other than the defined default units; 3) A result of 0 incorrectly reported when the system utilizes an expression that utilizes non-numerical symbols (e.g., > or <) to derive a calculated test as part of result reporting; 4) Reserve volume is enabled and the assay LIS code is not the same as the assay Test ID. These issues could potentially lead to erroneous results or delay reporting results for multiple analytes.
Recommended Action
Per FDA guidance
Beckman Coulter issued an URGENT MEDICAL DEVICE RECALL notice to its consignees on 12/21/2023 via US mail and email. The notices explained the issues with the devices, the impact on test results, and requested the following actions be taken: Issue 1 - Configure the Access Ultrasensitive Insulin assay to the system default units (IU/mL). Refer to the appropriate system manuals for instructions. To manually convert concentrations to SI units (pmol/L), multiply IU/mL by a multiplication factor of 7.0. Issue 2 - If the DxI 9000 Access Immunoassay Analyzer is connected to a host system, you can configure the host system to convert results from the system default units to the desired reporting units. If the DxI 9000 analyzer is not connected to a host system, revert all Access assays to their system default units to be sure the analyzer accurately reports dilution assay test results. Perform a retrospective review of all dilution assay test results that were reported in units other than the system default units. Issue 3 - Discontinue using the calculated result feature on the DxI 9000 user interface. Calculations can be performed manually or at the host system. For assay results that have already been run, if a calculated result of 0 was obtained, perform a retrospective review to ensure none of the assay results contained a > or < result. If any of the assay results contained a > or < then the calculated result interpretation should be corrected to no result . Issue 4 - If a reserve volume order is not run automatically as identified by a sample event notification, reload the sample to complete the ordered test. Alternatively, to ensure reserve volume is aliquoted, on the Menu > System Configuration > Test Menu screen, reenter the assay LIS code to match the assay Test ID shown on screen. Please share this information with your laboratory staff and retain this notification as part of your laboratory Quality System documentation. If you have
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 10, 2026